Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT00553566
Eligibility Criteria:
DISEASE CHARACTERISTICS:
Inclusion criteria:
* Enrolled on parent protocol CRUK-BCPP-2005-01
* Bladder lesion with cystoscopic characteristics compatible with urothelial cancer or transitional cell carcinoma
* Histologically proven urothelial cancer meeting one of the following criteria:
* Stage Ta (WHO grade 2/3, or grade 1 tumors that are either multifocal or \> 3 cm in size)
* Stage T1 (any grade)
* Stage Tis
Exclusion criteria:
* Previous diagnosis of cancer of the urethra, bladder, ureter, or renal pelvis within the 10 years prior to current diagnosis
PATIENT CHARACTERISTICS:
Inclusion criteria:
* Fit for cystoscopy and surgical biopsy/resection
Exclusion criteria:
* HIV infection
* Any condition that, in the opinion of the local investigator, might interfere with the safety of the patient or evaluation of the study objectives
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00553566
Study Brief:
Protocol Section:
NCT00553566